Origin Holdings Inc.

Chicago, IL · Founded 2009 · CIK 0001479869 · Biotech

Multimodal cancer biology datasets from patient tumor tissue including spatial transcriptomics, morphology, proteomics, and perturbation response data

origin.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$137M
2 Form D · Mar 2012
175 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$126,016,455
Private capital raisedForm D · SEC$11,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2884MYOLOGICA, LLC——
2885JANUSQ, LLC——
2886FEMTOFLUIDICS INCORPORATED——
2887Origin Holdings Inc.—$137M
2888RESVERLOGIX CORP.—$12M
2889Cullinan Therapeutics——
2890Network Music Partners, LLC—$205K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • John DrewDirector
  • Patrick GrantDirector · Executive Officer
  • Jeffrey KvamDirector · Executive Officer
  • Kenneth O'KeefeDirector
  • Grant PatrickDirector
  • John SpillerExecutive Officer
  • Brian VandenbergExecutive Officer
  • Gary VelasquezDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.